These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9917904)

  • 1. Advances in immunosuppression for heart transplantation.
    Kobashigawa JA
    Adv Card Surg; 1998; 10():155-74. PubMed ID: 9917904
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppressive approaches to the prevention of graft vascular disease.
    Gregory CR
    Transplant Proc; 1998 May; 30(3):878-80. PubMed ID: 9595134
    [No Abstract]   [Full Text] [Related]  

  • 3. [New immunosuppressive drugs in transplantation].
    Surdacka E; Sułowicz W; Surdacki A
    Przegl Lek; 1994; 51(8):347-54. PubMed ID: 7532870
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive agents: recent developments in molecular action and clinical application.
    Gerber DA; Bonham CA; Thomson AW
    Transplant Proc; 1998 Jun; 30(4):1573-9. PubMed ID: 9636637
    [No Abstract]   [Full Text] [Related]  

  • 5. Sirolimus to replace calcineurin inhibitors? Too early yet.
    Cravedi P; Ruggenenti P; Remuzzi G
    Lancet; 2009 Apr; 373(9671):1235-6. PubMed ID: 19362662
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: a randomized study.
    Potena L; Bianchi IG; Magnani G; Masetti M; Coccolo F; Fallani F; Russo A; Grigioni F; Branzi A; Ponticelli C
    Transplantation; 2010 Jan; 89(2):263-5. PubMed ID: 20098293
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine, FK-506 and other drugs in organ transplantation.
    Morris PJ
    Curr Opin Immunol; 1991 Oct; 3(5):748-51. PubMed ID: 1721824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of immunosuppressive drugs in transplantation.
    Triemer H
    J Med Assoc Ga; 1998 Apr; 87(2):93-6. PubMed ID: 16259250
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppressive regimens of tomorrow.
    Groth CG
    Transplant Proc; 1995 Dec; 27(6):2971-3. PubMed ID: 8539797
    [No Abstract]   [Full Text] [Related]  

  • 10. The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation.
    Hesse CJ; Vantrimpont P; van Riemsdijk-van Overbeeke IC; van Gelder T; Balk AH; Weimar W
    Transplant Proc; 2001 May; 33(3):2163-4. PubMed ID: 11377487
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants.
    Mueller XM
    Ann Thorac Surg; 2004 Jan; 77(1):354-62. PubMed ID: 14726104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of immunosuppression: the art and the science.
    Mancini MC; Cush EM; Launius BK; Brown PA
    Crit Care Nurs Q; 2004; 27(1):61-4. PubMed ID: 14974524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New horizons in immunosuppression.
    Simmons RL; Wang SC
    Transplant Proc; 1991 Aug; 23(4):2152-6. PubMed ID: 1714645
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness of sirolimus-based immunosuppression in ameliorating pre-transplant renal dysfunction in patients with Chagas' heart disease.
    Bestetti RB; Theodoropoulos TA; Nakazone MA; Dourado DA; Burdmann EA
    J Heart Lung Transplant; 2010 Nov; 29(11):1312-4. PubMed ID: 20719543
    [No Abstract]   [Full Text] [Related]  

  • 15. New immunosuppressive drugs in transplantation.
    Groth CG; Ohlman S; Gannedahl G; Ericzon BG
    Transplant Proc; 1993 Aug; 25(4):2681-3. PubMed ID: 7689274
    [No Abstract]   [Full Text] [Related]  

  • 16. Exceptional circumstances and heart transplantation.
    Coverdale A
    N Z Med J; 2005 Feb; 118(1209):U1290. PubMed ID: 15711623
    [No Abstract]   [Full Text] [Related]  

  • 17. [Advances in the fundamentals and therapeutic use of immunosuppressive agents].
    Ochiai T
    Arerugi; 1992 Mar; 41(3):381-4. PubMed ID: 1374229
    [No Abstract]   [Full Text] [Related]  

  • 18. Everolimus for cardiac allograft vasculopathy--every patient, at any time?
    Patel JK; Kobashigawa JA
    Transplantation; 2011 Jul; 92(2):127-8. PubMed ID: 21555972
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467
    [No Abstract]   [Full Text] [Related]  

  • 20. Controversies in heart and lung transplantation immunosuppression: tacrolimus versus cyclosporine.
    Kobashigawa JA
    Transplant Proc; 1998 Jun; 30(4):1095-7. PubMed ID: 9636445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.